- Home
- NEXT vs RCKT Comparison
NEXT vs RCKT Comparison
Compare NEXT & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEXT
- RCKT
- Stock Information
- Founded
- NEXT 2010
- RCKT 1999
- Country
- NEXT United States
- RCKT United States
- Employees
- NEXT N/A
- RCKT N/A
- Industry
- NEXT Oil & Gas Production
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- NEXT Energy
- RCKT Health Care
- Exchange
- NEXT Nasdaq
- RCKT Nasdaq
- Market Cap
- NEXT 2.0B
- RCKT 326.4M
- IPO Year
- NEXT N/A
- RCKT N/A
- Fundamental
- Price
- NEXT $8.91
- RCKT $2.48
- Analyst Decision
- NEXT
- RCKT Buy
- Analyst Count
- NEXT 0
- RCKT 13
- Target Price
- NEXT N/A
- RCKT $18.50
- AVG Volume (30 Days)
- NEXT 2.4M
- RCKT 4.7M
- Earning Date
- NEXT 08-13-2025
- RCKT 08-04-2025
- Dividend Yield
- NEXT N/A
- RCKT N/A
- EPS Growth
- NEXT N/A
- RCKT N/A
- EPS
- NEXT N/A
- RCKT N/A
- Revenue
- NEXT N/A
- RCKT N/A
- Revenue This Year
- NEXT N/A
- RCKT N/A
- Revenue Next Year
- NEXT N/A
- RCKT N/A
- P/E Ratio
- NEXT N/A
- RCKT N/A
- Revenue Growth
- NEXT N/A
- RCKT N/A
- 52 Week Low
- NEXT $4.27
- RCKT $2.19
- 52 Week High
- NEXT $9.71
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- NEXT 60.30
- RCKT 31.96
- Support Level
- NEXT $8.56
- RCKT $2.50
- Resistance Level
- NEXT $9.42
- RCKT $2.70
- Average True Range (ATR)
- NEXT 0.40
- RCKT 0.20
- MACD
- NEXT 0.03
- RCKT 0.11
- Stochastic Oscillator
- NEXT 61.63
- RCKT 4.82
About NEXT NextDecade Corporation
NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas and sale of LNG and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.